- Home
- AMLX vs GSL Comparison
AMLX vs GSL Comparison
Compare AMLX & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | GSL |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Greece |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMLX | GSL |
|---|---|---|
| Price | $14.54 | $39.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $21.56 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.1M | 350.1K |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 6.34% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.49 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $4.86 | $25.45 |
| 52 Week High | $18.61 | $42.70 |
Technical Indicators
Market Signals| Indicator | AMLX | GSL |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 56.34 |
| Support Level | $12.32 | $36.97 |
| Resistance Level | $15.37 | $39.91 |
| Average True Range (ATR) | 0.79 | 1.08 |
| MACD | 0.13 | 0.16 |
| Stochastic Oscillator | 81.78 | 94.09 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About GSL Global Ship Lease Inc New
Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.